Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Original Article

Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer

Online download statistics by month:

Online download statistics by month: January 2019 to March 2023

	Abstract	Full	Pdf
Jan 2019	128	10	2
Feb 2019	140	13	6
Mar 2019	86	8	6
Apr 2019	65	9	5
May 2019	60	3	2
Jun 2019	40	4	2
Jul 2019	53	4	1
Aug 2019	72	5	4
Sep 2019	111	1	0
Oct 2019	126	3	1
Nov 2019	47	1	0
Dec 2019	69	3	1
Jan 2020	82	2	3
Feb 2020	63	1	2
Mar 2020	71	2	1
Apr 2020	30	1	0
May 2020	57	1	1
Jun 2020	33	1	1
Jul 2020	81	5	3
Aug 2020	26	0	1
Sep 2020	38	4	1
Oct 2020	36	1	1
Nov 2020	35	1	1
Dec 2020	42	0	0
Jan 2021	101	1	0
Feb 2021	42	0	0
Mar 2021	76	0	0
Apr 2021	27	0	0
May 2021	15	0	0
Jun 2021	1	0	0
Jul 2021	3	3	0
Aug 2021	2	2	0
Sep 2021	1	1	0
Oct 2021	16	0	1
Nov 2021	9	0	0
Dec 2021	23	1	0
Jan 2022	24	2	1
Feb 2022	20	0	0
Mar 2022	35	1	3
Apr 2022	18	0	0
May 2022	42	0	0
Jun 2022	50	4	2
Jul 2022	34	0	0
Aug 2022	60	1	0
Sep 2022	37	0	0
Oct 2022	62	0	2
Nov 2022	32	0	0
Dec 2022	21	0	0
Jan 2023	11	1	0
Feb 2023	49	0	0
Mar 2023	15	0	0
Total	2417	100	54